<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04370132</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0212</org_study_id>
    <nct_id>NCT04370132</nct_id>
  </id_info>
  <brief_title>Segment IV Hypertrophy After Liver Venous Deprivation</brief_title>
  <official_title>Segment IV Hypertrophy After Liver Venous Deprivation Compared to Portal Embolization in Patient Before Major Hepatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      before major hepatectomy, in case of insufisant future liver remanent volume or function,
      portal embolization is a routinely used method to enable growth of the future liver remnant.
      Recently liver venous deprivation has been described in some pioneer centre. The results are
      processing with greater and faster hypertrophy allowing probably less drop out from the
      embolization to surgery compared to portal embolization.

      In major hepatectomy, and specially in right or extended right hepatectomy the segment IV
      plays an important role in the proportion of future liver remnant.

      Despite the growing interest in the scientific community for liver venous deprivation many
      aspects concerning the liver hypertrophy remains unexplored. In particular the the degree of
      hypertrophy of segment IV after liver venous deprivation compared to portal embolization.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2015</start_date>
  <completion_date type="Actual">April 15, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>segment IV degree of hypertrophy</measure>
    <time_frame>1 day</time_frame>
    <description>segment IV degree of hypertrophy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>5 years</time_frame>
    <description>overall Survival : overall survival : is overall survival from date of hepatic surgery until the 01/04/2020 or during 5 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrence free survival</measure>
    <time_frame>5 years</time_frame>
    <description>recurrence free Survival : is the the survival without same deasese recurrence from the hepatic surgery date until the 01/04/2020 or during 5 years</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Major Hepatectomy</condition>
  <arm_group>
    <arm_group_label>Group of patient with liver venous deprivation</arm_group_label>
    <description>Group of patient with liver venous deprivation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group of patient with portal embolization</arm_group_label>
    <description>Group of patient with portal embolization</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with liver tumors selected for surgery with insufficient futur liver remnant
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - patient with liver tumor selected for right hepatectomy with insufficient future liver
        remnant who have undergoes portal embolization or liver venous deprivation

        Exclusion criteria:

        - left / extended left hepatectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrizio PANARO, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UH MONTPELLIER</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uh Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2020</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

